Related Experiment Video

Updated: Aug 15, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

[Vascular impact of anti-hypertensive treatment and renal protection]

Carl Erik Mogensen1

  • 1Département de Médecine M, Aarhus Komunehospital, Hôpital Universitaire d'Aarhus, Aarhus, Danemark. carl.erik.mogensen@ki.au.dk

Current Medical Research and Opinion
|October 4, 2005
PubMed

Insights

Low-dose perindopril and indapamide effectively manage hypertension and protect kidneys, especially in diabetic patients. This combination significantly reduces blood pressure and albumin excretion, offering renoprotective benefits.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Context:

  • Hypertension accelerates kidney disease progression and structural changes.
  • Diabetic hypertension presents a growing challenge for renal health.
  • Microvascular changes and hypertension create a detrimental cycle impacting kidney function.

Purpose:

  • To evaluate the renoprotective effects of a low-dose combination of perindopril (an ACE inhibitor) and indapamide (a diuretic).
  • To compare the efficacy of perindopril/indapamide against enalapril in reducing blood pressure and albumin excretion.
  • To assess the impact of perindopril/indapamide on cardiovascular events and renal structure/function.

Summary:

  • Perindopril/indapamide demonstrated superior blood pressure reduction compared to enalapril.
  • This combination achieved a 24% greater reduction in albumin excretion, indicating significant renoprotection.
  • Animal studies suggest perindopril/indapamide offers protection to both renal structure and function.

Impact:

  • Highlights the therapeutic potential of perindopril/indapamide for hypertensive patients, particularly those with diabetes.
  • Suggests a new therapeutic strategy for preventing or slowing the progression of diabetic nephropathy.
  • Provides evidence for the renoprotective and potential cardiovascular benefits of this drug combination.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...